CVS Health Q4 revenue $105.7B (+8.2%); adj. EPS $1.09 vs $1.19; 2026 adj. EPS guide $7.00-$7.20

CVS HEALTH Corp

2025-FY EPS reported $1.39 revenue$402,067,000,000

Full-year 2025 revenue record $402.1B (+7.8%); GAAP EPS $1.39 (incl. $5.7B goodwill impairment), Adj. EPS $6.75 (+24.5%).
Q4 Health Care Benefits segment adj. op. loss ($676M) widened from ($439M) on IRA Medicare Part D seasonality.
Pharmacy & Consumer Wellness Q4 adj. op. income $1,911M (+8.7%) on higher prescription volume including Rite Aid acquisitions.
2026 guidance: GAAP EPS $5.94-$6.14; Adj. EPS $7.00-$7.20; cash flow from operations at least $9.0B (down from prior $10.0B).
Medical membership 26.6M, down 0.5M YoY; days claims payable 38.9 (down 3.6 days from Q3).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.